Nanoparticles covered with a mix of positively and negatively charged ligands aggregate into supraparticles in the lysosomes of cancer cells, disrupting the integrity of the lysosomal membrane and killing the cells without involving any anticancer drugs.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sun, T. et al. Angew. Chem. Int. Ed. 53, 12320–12364 (2014).
Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).
Lammers, T. et al. Nat. Rev. Mater. 1, 16069 (2016).
Wilhelm, S. et al. Nat. Rev. Mater. 1, 16014 (2016).
Borkowska, M. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-020-0643-3 (2020).
Gilroy, K. D. & Xia, Y. Chem. Asian J. 11, 2341–2351 (2016).
Damaghi, M., Wojtkowiak, J. W. & Gillies, R. J. Front. Physiol. 4, 370 (2013).
Domagala, A. et al. Int. J. Mol. Sci. 19, 2256 (2018).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Qiu, J., Xia, Y. Killing cancer cells by rupturing their lysosomes. Nat. Nanotechnol. 15, 252–253 (2020). https://doi.org/10.1038/s41565-020-0639-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-020-0639-z